Anixa Biosciences Advances Breast Cancer Vaccine and CAR-T Programs
August 24, 2026 | San Jose, California Anixa Biosciences announced that it will present updates on its breast cancer...
Anixa Biosciences
Advertisement
Anixa Biosciences Advances Ovarian Cancer CAR-T to Highest Dose
SAN JOSE, California, July 6, 2026 Anixa Biosciences, Inc. and Moffitt Cancer Center have announced a significant milestone in...
Anixa Wins First Korean Patent for Breast Cancer Vaccine
SAN JOSE, Calif., June 29, 2026 Anixa Biosciences, Inc. announced that the Korean Ministry of Intellectual Property (MOIP) has...
Anixa Biosciences Reports Positive Phase 1 Cancer Vaccine Data
June 26, 2026 | San Jose, California, USA Anixa Biosciences, Inc. announced encouraging clinical updates from its two leading...
Anixa Biosciences Highlights Clinical Immunotherapy Progress at Cancer Symposium
SAN JOSE, Calif., June 11, 2026 Anixa Biosciences, Inc. announced that two of its clinical-stage cancer immunotherapy programs will...
Advertisements
Anixa Advances Breast Cancer Vaccine to Phase 2 Trial
SAN JOSE, Calif., USA — April 1, 2026 In a significant advancement in cancer immunotherapy and clinical-stage biotechnology innovation,...
FDA Clears NexSys PCS Plasma System With Persona PLUS
BOSTON, Feb. 23, 2026 — Haemonetics Corporation announced that the U.S. Food and Drug Administration granted 510(k) clearance for...
Anixa CAR-T Breakthrough Highlighted at SCTR 2026
SAN JOSE, Calif., Feb. 23, 2026 — Anixa Biosciences announced that immunology leader Jose Conejo-Garcia, M.D., Ph.D., will keynote...
AI Drug Discovery Pact Targets Next-Gen Therapies
SAN DIEGO, Calif. & CAMBRIDGE, Mass., Feb. 9, 2026 — Clinical-stage life science technology company Iambic Therapeutics has entered...
Anixa Advances CAR-T Dose Escalation in Ovarian Cancer
SAN JOSE, Calif., Feb. 9, 2026 — Anixa Biosciences reported encouraging survival observations from its ongoing Phase 1 ovarian...
Advertisement
